Ardelyx Inc. buy WatchMen
Start price
13.12.23
/
0%
€4.91
Target price
13.12.24
-
Performance (%)
3.87%
End price
03.07.24
€5.10
Summary
This prediction ended on 03.07.24 with a price of €5.10. With a performance of 3.87%, the BUY prediction by WatchMen for Ardelyx Inc. closed with a slight gain. WatchMen has a follow-up prediction for Ardelyx Inc., but this time predicts that Ardelyx Inc. is a Sell.Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ardelyx Inc. | -1.408% | -1.408% |
| iShares Core DAX® | -0.612% | 0.567% |
| iShares Nasdaq 100 | -3.018% | -3.205% |
| iShares Nikkei 225® | -2.647% | 0.330% |
| iShares S&P 500 | -1.932% | -1.126% |
Comments by WatchMen for this prediction
In the thread Ardelyx Inc. diskutieren
Kursziel geändert auf 20,0
Kursziel gesetzt auf 20,0